how do the glp 1 drugs work Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment GLP-1 RA education

PubMed American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (Adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists

52 In a phase 1b trial done to evaluate the safety, pharmacokinetics and pharmacodynamics of orforglipron in patients with T2DM, orforglipron resulted in significant reductions in HbA1c, fasting blood glucose and body weight, with an adverse event profile consistent with that of other GLP-1RA

Wing RR, Phelan S

Int J Surg (2014) 12(12):14959

doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach

It is typically prescribed for short-term use only (12 weeks), though some physicians prescribe it longer